MALE CONTRACEPTION: CURRENT STATUS AND FUTURE PROSPECTS
- 1 October 1988
- journal article
- review article
- Published by Wiley in Clinical Endocrinology
- Vol. 29 (4) , 443-465
- https://doi.org/10.1111/j.1365-2265.1988.tb02894.x
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987
- The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic HyperplasiaNew England Journal of Medicine, 1987
- TRANSDERMAL TESTOSTERONE SUBSTITUTION THERAPY FOR MALE HYPOGONADISMThe Lancet, 1986
- Modulation of human colonic arachidonic acid metabolism by sulfasalazineDigestive Diseases and Sciences, 1985
- Hormonal effects of GnRH agonist in the human male: An approach to male contraception using combined androgen and GnRH agonist treatmentJournal of Steroid Biochemistry, 1985
- Dynamic study of serum gonadotrophin and testosterone levels in gossypol-treated men Long term follow-up study of 60 casesInternational Journal of Andrology, 1985
- Effects of Gossypol on the Seminiferous Epithelium in the Rat: A Light and Electron Microscope Study 1Biology of Reproduction, 1983
- Arachidonic acid-induced chemiluminescence of human polymorphonuclear leukocytesBiochemical and Biophysical Research Communications, 1982
- Reversible Inhibition of Testicular Steroidogenesis and Spermatogenesis by a Potent Gonadotropin-Releasing Hormone Agonist in Normal MenNew England Journal of Medicine, 1981
- Suppression of human spermatogenesis by depot androgen: Potential for male contraceptionJournal of Steroid Biochemistry, 1979